You searched for "innovation"
Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 1)
1 December 2021
| Rosalind Harrison
|
EYE - General
Are we doing enough to meet the current demands on ophthalmic services? In part one of a two-part series (see Part 2 here), Rosalind Harrison takes a look at how efficiency has been improved in eyecare services in the US....
Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa
1 June 2022
| Fatima Kyari, Affiong Ibanga, Adeola Onakoya, Heiko Philippin, Winifred Nolan, William Dean, Marcia Zondervan, Covadonga Bascaran, Andrew Tatham
|
EYE - Cornea, EYE - General
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...
Prevalence of acute anterior uveitis in diabetic patients attending diabetic eye disease clinics
The authors share their investigation at Manchester Royal Eye Hospital into the association between diabetes and AAU. The global prevalence of diabetes mellitus (DM) is rapidly rising from an estimated 9.3% in 2019 to 10.2% by 2030 [1]. The link...See sweet to C-suite: Peter Holland
4 December 2024
| David Lockington
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
See also - See sweet to C-suite: Imran Rahman In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part One: David speaks...
Things I’d tell my medical school self, had I known my first year on the job would be during a global pandemic
5 June 2020
| Nikolaos Tzoumas
|
EYE - General
In a conversation with his younger self, a foundation doctor reflects on the contrast between his expectations of medicine at university and the reality of working during the coronavirus pandemic. Every doctor arrives at medical school with nervous anticipation, yet...
Harry Moss Traquair: Edinburgh Ophthalmologist and Father Figure of Perimetry
3 February 2023
| Andrew King
|
EYE - General
It is a unique honour bestowed upon only a few clinicians, that their name becomes for evermore associated with the subject of their particular expertise and knowledge. Such an individual is undoubtedly Harry Moss Traquair, an Edinburgh-based ophthalmologist, who in...
The last three patients: dermatology (Patient Three)
3 August 2023
| Jonathan Rees (Prof)
For the third and final reflection in this series (see Part 1 and Part 2), Professor Jonathan Rees recounts his experience of a patient with cancer who was failed by the NHS, and how their inadequate treatment illuminates some issues...
Binocular single vision (BSV)
3 April 2023
| Ali Yagan
|
EYE - General
Introduction In this article I will try to summarise some of the definitions, tests and assessments performed in the strabismus clinic to assess patient binocular potential. This is a key feature of strabismus assessment, especially in adults, and it will...
Diabetic Retinopathy Network laser training programme
5 February 2020
| Nick Astbury, Denise Mabey, Joachim Kilemile, William Makupa, Marcia Zondervan
|
EYE - Vitreo-Retinal, EYE - General
The VISION 2020 Diabetic Retinopathy Network (DR-NET) was established in 2014 to tackle the increasing burden of diabetes and diabetic retinopathy (DR) in developing countries [1]. By forming a network of long-term LINK capacity-building partnerships, learning and best practice can...
Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.Acute retinal necrosis presumably caused by Epstein-Barr virus infection
1 October 2015
| Antigoni Koukkoulli, Mark Cachia Markman, Anindita Homchoudhury, Oliver Backhouse
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Acute retinal necrosis (ARN) is an uncommon, but serious and potentially blinding condition. ARN is characterised by panuveitis, occlusive vasculopathy and progressive peripheral necrotising retinitis. The diagnosis is clinical but confirmation is sought via aqueous and vitreous sampling. Varicella zoster...
The madarosis mystery: unravelling the clues to a host of health issues
4 October 2023
| Kate Reed, Anna Gkountelia
|
EYE - Cornea
Eyelash madarosis is a medical condition characterised by the loss of eyelashes caused by the destruction of hair follicles. It can range from a few missing lashes to a complete absence of lashes on the eyelids. This condition can be...
